Literature DB >> 7821964

Influence of CD28 co-stimulation on cytokine production is mainly regulated via interleukin-2.

H M Kuiper1, R de Jong, M Brouwer, K Lammers, J Wijdenes, R A van Lier.   

Abstract

Interaction of CD28 with its ligand B7 plays an important role in the initiation of immune responses. The co-stimulatory signal generated by cross-linking of CD28 molecules results in enhanced T-cell proliferation and augmentation of cytokine production. In particular, mRNA levels of T-helper 1 (Th1)-type cytokines, such as interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) are reported to be strongly increased. We investigated the effect of CD28 co-stimulation on the production of Th2-type cytokines. CD28 mAb induced a strong augmentation of IL-2 secretion in activated T-cell clones. Production of IFN-gamma was also enhanced, but the increase in IL-4 secretion was generally moderate. Augmentation of IL-4 production by CD28 was most pronounced in clones that produced low amounts of IL-2, compared to clones producing high levels of IL-2. It was found that the up-regulation of IL-4 by CD28 co-stimulation was mainly controlled indirectly via an increase of IL-2. Some clones could produce IL-4 in an IL-2-independent manner; in these situations CD28 co-stimulation had no augmenting effect on the production of IL-4. The secretion of IL-4 by peripheral blood CD4+ T cells, that were activated with B7-expressing transfectants, was also found to be dependent on IL-2. Finally, Northern blot analysis confirmed that co-stimulation of CD28 primarily affected IL-2 production, and that inhibition of IL-2/IL-2 receptor interaction abolished the augmenting action of CD28 monoclonal antibody on the production of the Th2-type cytokines IL-4, IL-5 and IL-10 and of the Th1 cytokine IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7821964      PMCID: PMC1415021     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  47 in total

1.  The interleukin 2 CD28-responsive complex contains at least three members of the NF kappa B family: c-Rel, p50, and p65.

Authors:  P Ghosh; T H Tan; N R Rice; A Sica; H A Young
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

2.  IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells.

Authors:  H Yssel; R De Waal Malefyt; M G Roncarolo; J S Abrams; R Lahesmaa; H Spits; J E de Vries
Journal:  J Immunol       Date:  1992-10-01       Impact factor: 5.422

3.  Regulation of interleukin-4 production in human mononuclear cells.

Authors:  W Holter; O Majdic; F S Kalthoff; W Knapp
Journal:  Eur J Immunol       Date:  1992-10       Impact factor: 5.532

4.  Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4.

Authors:  L Chen; S Ashe; W A Brady; I Hellström; K E Hellström; J A Ledbetter; P McGowan; P S Linsley
Journal:  Cell       Date:  1992-12-24       Impact factor: 41.582

5.  Murine B7 antigen provides a sufficient costimulatory signal for antigen-specific and MHC-restricted T cell activation.

Authors:  F Galvin; G J Freeman; Z Razi-Wolf; W Hall; B Benacerraf; L Nadler; H Reiser
Journal:  J Immunol       Date:  1992-12-15       Impact factor: 5.422

6.  Murine B7 antigen provides an efficient costimulatory signal for activation of murine T lymphocytes via the T-cell receptor/CD3 complex.

Authors:  H Reiser; G J Freeman; Z Razi-Wolf; C D Gimmi; B Benacerraf; L M Nadler
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

7.  Disruption of the murine IL-4 gene blocks Th2 cytokine responses.

Authors:  M Kopf; G Le Gros; M Bachmann; M C Lamers; H Bluethmann; G Köhler
Journal:  Nature       Date:  1993-03-18       Impact factor: 49.962

8.  Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule.

Authors:  P S Linsley; P M Wallace; J Johnson; M G Gibson; J L Greene; J A Ledbetter; C Singh; M A Tepper
Journal:  Science       Date:  1992-08-07       Impact factor: 47.728

9.  Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells.

Authors:  S E Townsend; J P Allison
Journal:  Science       Date:  1993-01-15       Impact factor: 47.728

10.  Functional expression of B7/BB1 on activated T lymphocytes.

Authors:  M Azuma; H Yssel; J H Phillips; H Spits; L L Lanier
Journal:  J Exp Med       Date:  1993-03-01       Impact factor: 14.307

View more
  3 in total

1.  Expression of both B7-1 and CD28 contributes to the IL-2 responsiveness of CTLL-2 cells.

Authors:  R Belani; G J Weiner
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

2.  Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells.

Authors:  A Agathanggelou; G Niedobitek; R Chen; J Nicholls; W Yin; L S Young
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

3.  Presence, function, and regulation of IL-17F-expressing human CD4+ T cells.

Authors:  Lachrissa A Burns; Ash Maroof; Diane Marshall; Kathryn J A Steel; Sylvine Lalnunhlimi; Suzanne Cole; Anca Catrina; Bruce Kirkham; Leonie S Taams
Journal:  Eur J Immunol       Date:  2020-01-16       Impact factor: 5.532

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.